Literature DB >> 29883318

Specificity profiling of human trypsin-isoenzymes.

Oliver Schilling1,2,3, Martin L Biniossek1, Bettina Mayer1, Brigitta Elsässer4, Hans Brandstetter4, Peter Goettig4, Ulf-Håkan Stenman5, Hannu Koistinen5.   

Abstract

In humans, three different trypsin-isoenzymes have been described. Of these, trypsin-3 appears to be functionally different from the others. In order to systematically study the specificity of the trypsin-isoenzymes, we utilized proteome-derived peptide libraries and quantitative proteomics. We found similar specificity profiles dominated by the well-characterized preference for cleavage after lysine and arginine. Especially, trypsin-1 slightly favored lysine over arginine in this position, while trypsin-3 did not discriminate between them. In the P1' position, which is the residue C-terminal to the cleavage site, we noticed a subtle enrichment of alanine and glycine for all three trypsins and for trypsin-3 there were additional minor P1' and P2' preferences for threonine and aspartic acid, respectively. These findings were confirmed by FRET peptide substrates showing different susceptibility to cleavage by different trypsins. The preference of trypsin-3 for aspartic acid in P2' is explained by salt bridge formation with the unique Arg193. This salt bridge enables and stabilizes a canonical oxyanion conformation by the amides of Ser195 and Arg193, thus manifesting a selective substrate-assisted catalysis. As trypsin-3 has been proposed to be a therapeutic target and marker for cancers, our results may aid the development of specific inhibitors for cancer therapy and diagnostic probes.

Entities:  

Keywords:  profiling; protease; specificity; substrate-assisted catalysis; trypsin

Mesh:

Substances:

Year:  2018        PMID: 29883318     DOI: 10.1515/hsz-2018-0107

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  7 in total

1.  Evaluation of the site-unspecified peptide identification method for proteolytic peptide mapping.

Authors:  H B Wang; F Zeng; Y Y Wang; X Li; Y M Li; Y F Wang; Y H Liu; F P Lu
Journal:  RSC Adv       Date:  2020-10-07       Impact factor: 3.361

Review 2.  Origin and Expansion of the Serine Protease Repertoire in the Myelomonocyte Lineage.

Authors:  Stefanie A I Weiss; Salome R T Rehm; Natascha C Perera; Martin L Biniossek; Oliver Schilling; Dieter E Jenne
Journal:  Int J Mol Sci       Date:  2021-02-07       Impact factor: 5.923

3.  Potent Inhibitor of Human Trypsins from the Aeruginosin Family of Natural Products.

Authors:  Muhammad N Ahmed; Matti Wahlsten; Jouni Jokela; Matthias Nees; Ulf-Håkan Stenman; Danillo O Alvarenga; Tomas Strandin; Kaarina Sivonen; Antti Poso; Perttu Permi; Mikko Metsä-Ketelä; Hannu Koistinen; David P Fewer
Journal:  ACS Chem Biol       Date:  2021-10-18       Impact factor: 5.100

4.  Biophysical and Biochemical Characterization of the Receptor Binding Domain of SARS-CoV-2 Variants.

Authors:  Ritika Khatri; Hilal Ahmad Parray; Gazala Siddiqui; Adarsh Kumar Chiranjivi; Sneha Raj; Rachel Kaul; Vikas Maithil; Sweety Samal; Shubbir Ahmed
Journal:  Protein J       Date:  2022-09-01       Impact factor: 4.000

5.  Exome Sequencing Reveals Genetic Variability and Identifies Chronic Prognostic Loci in Chinese Sarcoidosis Patients.

Authors:  Qian Zhang; Hui Huang; Meijun Zhang; Chuling Fang; Na Wang; Xiaoyan Jing; Jian Guo; Wei Sun; Xiaoyu Yang; Zuojun Xu
Journal:  Front Oncol       Date:  2022-07-04       Impact factor: 5.738

Review 6.  Is There a Trojan Horse to Aggressive Pancreatic Cancer Biology? A Review of the Trypsin-PAR2 Axis to Proliferation, Early Invasion, and Metastasis.

Authors:  Kjetil Søreide; Marcus Roalsø; Jan Rune Aunan
Journal:  J Pancreat Cancer       Date:  2020-02-06

7.  Transcriptomic Alterations in Water Flea (Daphnia magna) following Pravastatin Treatments: Insect Hormone Biosynthesis and Energy Metabolism.

Authors:  Yuan Lei; Jiahua Guo; Qiqi Chen; Jiezhang Mo; Yulu Tian; Hisato Iwata; Jinxi Song
Journal:  Toxics       Date:  2022-02-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.